glp-1 levels in type 2 diabetes Agonist Effects on Glucagon Suppression BMI & the Role of

& Petrovich, G

The ongoing multidistrict litigation (MDL) against pharmaceutical giants Novo Nordisk and Eli Lilly concerning GLP-1 drugs, including Ozempic, Wegovy, Trulicity, and Mounjaro, continues to develop as plaintiffs claim these medications have caused serious gastrointestinal injuries

But its not a simple problem of low GLP-1 = bad

Through a retrospective review of cutaneous adverse events associated with semaglutide, dulaglutide, tirzepatide, lixisenatide, liraglutide, and exenatide in the FDA Adverse Event Reporting System, it was found that the 5 most common cutaneous reactions associated with GLP-1 agonists were eczematous, pruritus, drug eruptions, hyperhidrosis, and alopecia

And while I dont think animal studies are worthless, theyre preliminary

Less Common Side Effects Injection site reactions: Usually minor redness or irritation